189 related articles for article (PubMed ID: 21471518)
21. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Fujikawa H; Matsusita K; Kawamura M; Inoue Y; Miki C; Kusunoki M
Int J Oncol; 2011 Mar; 38(3):655-63. PubMed ID: 21240461
[TBL] [Abstract][Full Text] [Related]
23. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
24. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
[TBL] [Abstract][Full Text] [Related]
25. A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer.
Casado E; García VM; Sánchez JJ; Blanco M; Maurel J; Feliu J; Fernández-Martos C; de Castro J; Castelo B; Belda-Iniesta C; Sereno M; Sánchez-Llamas B; Burgos E; García-Cabezas MÁ; Manceñido N; Miquel R; García-Olmo D; González-Barón M; Cejas P
Clin Cancer Res; 2011 Jun; 17(12):4145-54. PubMed ID: 21467161
[TBL] [Abstract][Full Text] [Related]
26. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
27. Increase in Gene Expression of TYMP, DPYD and HIF1A Are Associated with Response to Preoperative Chemoradiotherapy Including S-1 or UFT for Rectal Cancer.
Sadahiro S; Suzuki T; Tanaka A; Okada K; Saito G; Kamijo A; Nagase H
Anticancer Res; 2016 May; 36(5):2433-40. PubMed ID: 27127154
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.
Jakob C; Liersch T; Meyer W; Baretton GB; Schwabe W; Häusler P; Kulle B; Becker H; Aust DE
Am J Surg Pathol; 2006 Sep; 30(9):1169-74. PubMed ID: 16931962
[TBL] [Abstract][Full Text] [Related]
29. Extracellular matrix proteins and chemoradiotherapy: alpha5beta1 integrin as a predictive marker in rectal cancer.
Jayne DG; Heath RM; Dewhurst O; Scott N; Guillou PJ
Eur J Surg Oncol; 2002 Feb; 28(1):30-6. PubMed ID: 11869010
[TBL] [Abstract][Full Text] [Related]
30. [A Case Report of a Pathological Complete Response of Rectal Cancer to Preoperative Chemoradiotherapy with Tegafur].
Morikawa T; Teraishi F; Shima Y; Iwata J
Gan To Kagaku Ryoho; 2016 Mar; 43(3):381-4. PubMed ID: 27067861
[TBL] [Abstract][Full Text] [Related]
31. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Kawamoto A; Yasuda H; Inoue Y; Miki C; Kusunoki M
Ann Surg Oncol; 2010 Aug; 17(8):2051-8. PubMed ID: 20177796
[TBL] [Abstract][Full Text] [Related]
32. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
Moore HG; Shia J; Klimstra DS; Ruo L; Mazumdar M; Schwartz GK; Minsky BD; Saltz L; Guillem JG
Ann Surg Oncol; 2004 Nov; 11(11):955-61. PubMed ID: 15525823
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy.
Uchida K; Schneider S; Yochim JM; Kuramochi H; Hayashi K; Takasaki K; Yang D; Danenberg KD; Danenberg PV
Clin Cancer Res; 2005 May; 11(9):3363-8. PubMed ID: 15867236
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
Min BS; Choi YJ; Pyo HR; Kim H; Seong J; Chung HC; Rha SY; Kim NK
Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
[TBL] [Abstract][Full Text] [Related]
35. [A case of carcinoma associated with anal fistula resected after preoperative chemoradiotherapy].
Sato Y; Ohki S; Sassa M; Tachibana K; Ando J; Endo Y; Suzuki S; Nakamura I; Koyama Y; Suzuki S; Takenoshita S
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1341-3. PubMed ID: 21829077
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of LGR5 and CD44 expression in locally advanced rectal cancer after preoperative chemoradiotherapy.
Saigusa S; Inoue Y; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Uchida K; Mohri Y; Kusunoki M
Int J Oncol; 2012 Nov; 41(5):1643-52. PubMed ID: 22923071
[TBL] [Abstract][Full Text] [Related]
37. Oncologic outcomes of pathologic stage I lower rectal cancer with or without preoperative chemoradiotherapy: are they comparable?
Huh JW; Kim CH; Kim HR; Kim YJ
Surgery; 2011 Nov; 150(5):980-4. PubMed ID: 21875732
[TBL] [Abstract][Full Text] [Related]
38. [Preoperative chemoradiotherapy for resectable lower rectal cancer].
Takase S; Kamigaki T; Yamashita K; Nakamura T; Nishimura H; Sasaki R
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2006-8. PubMed ID: 20037306
[TBL] [Abstract][Full Text] [Related]
39. Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer.
Korkeila EA; Syrjänen K; Bendardaf R; Laulajainen M; Carpén O; Pyrhönen S; Sundström J
Hum Pathol; 2011 Mar; 42(3):384-92. PubMed ID: 21190723
[TBL] [Abstract][Full Text] [Related]
40. Complete pathologic response after preoperative rectal cancer chemoradiotherapy.
Ciccocioppo A; Stephens JH; Hewett PJ; Rieger NA
ANZ J Surg; 2009 Jun; 79(6):481-4. PubMed ID: 19566874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
